Louise A Cullen1, Nicholas L Mills2, Simon Mahler3, Richard Body4. 1. Royal Brisbane and Women's Hospital, Brisbane, Australia; louise.cullen@health.qld.gov.au. 2. BHF Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, UK. 3. Wake Forest School of Medicine, Winston-Salem, NC. 4. Central Manchester University Hospitals NHS Foundation Trust, UK.
Abstract
BACKGROUND: Patients with chest pain comprise a large proportion of emergency presentations and place a major burden on healthcare resources. Therefore, efforts to safely and rapidly identify those with and without acute myocardial infarction (AMI) are needed. The challenge for clinicians is to accurately identify patients with acute coronary syndromes, while balancing the need to safely and rapidly reassure and discharge those without serious conditions. CONTENT: This review summarizes the evidence to date on optimum accelerated strategies for the rule-in and rule-out of AMI, using strategies focused on optimum use of troponin results. Evidence based on both sensitive and highly sensitive troponin assay results is presented. The use of novel biomarkers is also addressed and the combination of biomarkers with other clinical information in accelerated diagnostic strategies is discussed. SUMMARY: The majority of patients, who are not at risk of myocardial infarction or other serious harm, may be suitable for discharge directly from the emergency setting using approaches focused on troponin algorithms and accelerated diagnostic protocols. Evidence about the clinical and health economic impact of use of such strategies is needed, as they may have major benefits for both patients and healthcare providers.
BACKGROUND: Patients with chest pain comprise a large proportion of emergency presentations and place a major burden on healthcare resources. Therefore, efforts to safely and rapidly identify those with and without acute myocardial infarction (AMI) are needed. The challenge for clinicians is to accurately identify patients with acute coronary syndromes, while balancing the need to safely and rapidly reassure and discharge those without serious conditions. CONTENT: This review summarizes the evidence to date on optimum accelerated strategies for the rule-in and rule-out of AMI, using strategies focused on optimum use of troponin results. Evidence based on both sensitive and highly sensitive troponin assay results is presented. The use of novel biomarkers is also addressed and the combination of biomarkers with other clinical information in accelerated diagnostic strategies is discussed. SUMMARY: The majority of patients, who are not at risk of myocardial infarction or other serious harm, may be suitable for discharge directly from the emergency setting using approaches focused on troponin algorithms and accelerated diagnostic protocols. Evidence about the clinical and health economic impact of use of such strategies is needed, as they may have major benefits for both patients and healthcare providers.
Authors: Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch Journal: Basic Res Cardiol Date: 2018-08-17 Impact factor: 17.165
Authors: Alexey V Orlov; Juri A Malkerov; Denis O Novichikhin; Sergey L Znoyko; Petr I Nikitin Journal: Int J Mol Sci Date: 2022-04-19 Impact factor: 6.208
Authors: Ian Gunsolus; Yader Sandoval; Stephen W Smith; Anne Sexter; Karen Schulz; Charles A Herzog; Fred S Apple Journal: J Am Soc Nephrol Date: 2017-10-27 Impact factor: 10.121
Authors: Merry L Lindsey; Roberto Bolli; John M Canty; Xiao-Jun Du; Nikolaos G Frangogiannis; Stefan Frantz; Robert G Gourdie; Jeffrey W Holmes; Steven P Jones; Robert A Kloner; David J Lefer; Ronglih Liao; Elizabeth Murphy; Peipei Ping; Karin Przyklenk; Fabio A Recchia; Lisa Schwartz Longacre; Crystal M Ripplinger; Jennifer E Van Eyk; Gerd Heusch Journal: Am J Physiol Heart Circ Physiol Date: 2018-01-12 Impact factor: 4.733
Authors: Ayesha Khan; Muhammad S Saleem; Keith D Willner; Luke Sullivan; Elsie Yu; Osama Mahmoud; Amro Alsaid; Martin E Matsumura Journal: JAMA Netw Open Date: 2022-08-01
Authors: Andrew R Chapman; Kerrick Hesse; Jack Andrews; Kuan Ken Lee; Atul Anand; Anoop S V Shah; Dennis Sandeman; Amy V Ferry; Jack Jameson; Simran Piya; Stacey Stewart; Lucy Marshall; Fiona E Strachan; Alasdair Gray; David E Newby; Nicholas L Mills Journal: Circulation Date: 2018-10-16 Impact factor: 29.690
Authors: Ryan Wereski; Dorien M Kimenai; Caelan Taggart; Dimitrios Doudesis; Kuan Ken Lee; Matthew T H Lowry; Anda Bularga; David J Lowe; Takeshi Fujisawa; Fred S Apple; Paul O Collinson; Atul Anand; Andrew R Chapman; Nicholas L Mills Journal: Circulation Date: 2021-06-25 Impact factor: 29.690